WallStreetZenWallStreetZen

NASDAQ: INVO
Invo Bioscience Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their INVO stock forecasts and price targets.

Forecast return on equity

Is INVO forecast to generate an efficient return?
Company
4,737.85%
Industry
23.66%
Market
90.31%
INVO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INVO forecast to generate an efficient return on assets?
Company
68.14%
Industry
12.57%
INVO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INVO revenue growth forecast

How is INVO forecast to perform vs Medical Devices companies and vs the US market?
Company
398.91%
Industry
7.03%
Market
8.84%
INVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INVO vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
INVO$0.30N/AN/A
BJDX$0.21N/AN/A
HSDT$0.17$1.00+502.41%Strong Buy
NUWE$3.06N/AN/A
INBS$2.79N/AN/A

Invo Bioscience Stock Forecast FAQ

What is INVO's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: INVO) forecast ROE is 4,737.85%, which is considered strong.

If you're new to stock investing, here's how to buy Invo Bioscience stock.

What is INVO's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: INVO) forecast ROA is 68.14%, which is higher than the forecast US Medical Devices industry average of 12.57%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.